S. Brouard et al., Prolongation of heart xenograft survival in a hamster-to-rat model after therapy with a rationally designed immunosuppressive peptide, TRANSPLANT, 67(12), 1999, pp. 1614-1618
Background Modification of the aminoacid sequence of peptides derived hom t
he HLA class I heavy chain in combination with computer rational design res
ulted in the development of a peptide, RDP1258, with enhanced immunosuppres
sive activity.
Methods. We evaluated the activity of this peptide, analyzing infiltrate by
immunohistology and cytokine transcripts by reverse transcriptase-polymera
se chain reaction method, in a hamster-to-rat xenograft model where recipie
nts were treated with cobra venom factor (CVF) and peptide.
Results. Although CVF or peptide alone had no effect, a combination of CVF/
peptide RDP1258 resulted in a significant prolongation of graft survival (7
.9+/-1 vs. 4.5+/-0 and 3.5+/-0 days, P<0.001). This effect was associated w
ith an increased expression, of heme oxygenase 1 (HO-1) in spleen, a signif
icant reduced graft infiltrate, and a decrease of tumor necrosis factor-alp
ha mRNA transcripts (P<0.05) compared with CVF-treated recipients (1.6+/-0.
07 vs. 3.3+/-0.3%, P=0.001) on day 3 after transplantation.
Conclusion. These observations are consistent with the observation that up-
regulation of HO-1 results in inhibition of immune effector functions and s
uggest that the peptide acts, at least partially, through HO-1 regulation.